The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online
doi:10.1084/jem.20071088
The Journal of Experimental Medicine, Vol. 205, No. 1, 155-168
The Rockefeller University Press, 0022-1007 $30.00
© Meyer-Bahlburg et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 5465K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meyer-Bahlburg, A.
Right arrow Articles by Rawlings, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meyer-Bahlburg, A.
Right arrow Articles by Rawlings, D. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

 Characterization of a late transitional B cell population highly sensitive to BAFF-mediated homeostatic proliferation

Almut Meyer-Bahlburg1, Sarah F. Andrews2, Karl O.A. Yu3, Steven A. Porcelli3, and David J. Rawlings1,2

1 Department of Pediatrics and 2 Department of Immunology, University of Washington School of Medicine, Seattle, WA 98195
3 Department of Microbiology and Immunology, Albert Einstein College of Medicine Bronx, NY 10461

CORRESPONDENCE David J. Rawlings:drawling{at}u.washington.edu

We have characterized a distinct, late transitional B cell subset, CD21int transitional 2 (T2) B cells. In contrast to early transitional B cells, CD21int T2 B cells exhibit augmented responses to a range of potential microenvironmental stimuli. Adoptive transfer studies demonstrate that this subset is an immediate precursor of both follicular mature and marginal zone (MZ) B cells. In vivo, a large percentage of CD21int T2 B cells has entered the cell cycle, and the cycling subpopulation exhibits further augmentation in mitogenic responses and B cell-activating factor of the TNF family (BAFF) receptor expression. Consistent with these features, CD21int T2 cells exhibit preferential responses to BAFF-facilitated homeostatic signals in vivo. In addition, we demonstrate that M167 B cell receptor (BCR) idiotypic-specific B cells are first selected within the cycling CD21int T2 population, ultimately leading to preferential enrichment of these cells within the MZ B cell compartment. These data, in association with the coordinate role for BAFF and microenvironmental cues in determining the mature BCR repertoire, imply that this subset functions as a unique selection point in peripheral B cell development.

Abbreviations used: AAD, amino actinomycin D; BAFF, B cell-activating factor of the TNF family; BAFF-R, BAFF receptor; BCR, B cell receptor; FM, follicular mature; HP, homeostatic proliferation; KREC, {kappa}-deleting recombination excision circle; MZ, marginal zone; MZP, MZ precursor; PC, phosphorylcholine; TLR, Toll-like receptor.

A. Meyer-Bahlburg and S.F. Andrews contributed equally to this paper.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS